Clinical Trials
32 trialsOHGW-ACP
Azienda USL Reggio Emilia - IRCCS
EHCancer
Zagazig University
A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell Malignancies
Sheba Medical Center
ALHERT
University Hospital, Angers
EscrimHEMA
University Hospital, Angers
Primary Prostatic Lymphoma on a 66 Year-old Male in Mexico.
Instituto Mexicano del Seguro Social
Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia
Tel-Aviv Sourasky Medical Center
PRIMARY TESTICULAR LYMPHOMA
Instituto Mexicano del Seguro Social
Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma
Henan Cancer Hospital
The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia
Anhui Provincial Hospital
TEAM
Sheba Medical Center
Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
The Affiliated People's Hospital of Ningbo University
RAT-HEMATO
University Hospital, Angers
Integrative Medicine in Lymphoma Survivors
Bnai Zion Medical Center
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies
The Affiliated People's Hospital of Ningbo University
The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19
Tel-Aviv Sourasky Medical Center
Applying PET/MR in Oncology - a Prospective Project
Tel-Aviv Sourasky Medical Center
Non-invasive Evaluation of Lymphoma Patients Based on Artificial Intelligence and PET/MRI
Tel-Aviv Sourasky Medical Center
MILY
Turku University Hospital
Clinical Application of Polyethylene Glycol Liposome Doxorubicin (PLD) in Primary Lymphoma
Shandong Provincial Hospital
pSS
National Council of Scientific and Technical Research, Argentina
Cytoplasmic Activated PD-1 CAR T Cells in Refractory/Relapsed B Cell Lymphoma
Henan Cancer Hospital
Lonquek for Autologous Stem Cell Mobilization
Sheba Medical Center
Relinfo
Instituto Nacional de Cancer, Brazil
ECHO
National Cancer Center, Korea
CareSSE
University Hospital, Angers
Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma
Bayside Health
Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma
Bayside Health
Efficacy Study of Outpatient Therapy for Lymphoma
Bayside Health
IPTAS
Centro Nazionale Sangue
HBVNHL
Taipei Veterans General Hospital, Taiwan
Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin (ESHAOx) for Refractory or Relapsed Hodgkin's Lymphoma (HL)
National Cancer Center, Korea